In the same in vitro study, it was shown that the majority of the investigated complement factors as C3a and C5a and the complement regulatory proteins CD35, CD46, CD55, and CD59 were expressed at a significantly lower level in nonarticular chondrocytes compared to articular chondrocytes.
The investigated complement molecules were C1r/s, C3, C4, C5, factor I, factor B/C2-A (Bf/C2-A), mannose-binding lectin (MBL) and MBL-associated serine protease (MASP).
In order to verify if the complement system can be activated in the anterior midgut of blood fed triatomines and other insects such as mosquitoes and phebotomines, the performance of the human complement was investigated by measuring the level of C3b deposition in the classical and alternative pathways at pHs 6.0 to 8.5 with 0.5 pH unit intervals.
The capabilities of four commonly used linkage-learning metrics, nonlinearity, entropy, simultaneity and differential mutual complement, are investigated based on the above definitions.
Possibilities include use of temporal FST or the allele frequency spectrum to monitor another aspect of genetic erosion (drift in allele frequencies); these could complement the indicators we investigated (Schwartz et al. 2007).
Through implementing new policy recommendations and LED-based fluorescence microscopy the current laboratory staff complement could investigate the same number of patients, examining auramine-stained smears to an extent that is equivalent to a 10 minutes ZN smear examination.
Here, by utilizing sera with selected deletion of complement proteins, we investigated whether each individual complement protein regulates the activation of tumor suppressors and kinase proteins in human prostate DU145 cells.
Around 130 MPs, mostly Labour, have signed a Commons motion calling for the creation of a High Pay Commission to complement the Low Pay Commission by investigating pay at the top of the earnings scale.
Thus, genetic and gonadal sex are dissociated in the FCG mice, and the contribution of sex chromosome complement can be investigated independently (reviewed in [ 75]).
The long-term safety and efficacy of eculizumab, a humanized monoclonal antibody that inhibits terminal complement activation, was investigated in 195 patients over 66 months.
